Identification of the potentially arrhythmogenic substrate in the acute phase of ST-segment elevation myocardial infarction
Diego Penela(Hospital Quirón Teknon), Antonio Berruezo(Hospital Quirón Teknon), Wladimiro Jiménez(Universitat de Barcelona), Rosario J. Perea(Hospital Clínic de Barcelona), David Soto‐Iglesias(Hospital Quirón Teknon), Teresa M. de Caralt(European Molecular Biology Laboratory), Manuel Morales‐Ruiz(Universitat de Barcelona), Lluı́s Mont(Hospital Clínic de Barcelona), Juan Fernández‐Armenta(Hospital Universitario Puerta del Mar), S Prat(Universitat de Barcelona), Luis Lasalvia(Medical Solutions), Vanessa Hervàs(Universitat de Barcelona), Xavier Bosch(Universitat de Barcelona), Roger Borràs(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), David Andreu(Universitat Pompeu Fabra), Juan Acosta(Hospital Universitario Virgen del Rocío), Okan Ekinci(Siemens Healthineers (Germany)), Áurea Mira(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Jose T. Ortiz‐Pérez(Hospital Quirón Teknon)
Cited by 14
Related Papers
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
|Journal of the American College of Cardiology|2013|631
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
|Radiographics|2010|490
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461
Gender Differences in Clinical Manifestations of Brugada Syndrome
|Journal of the American College of Cardiology|2008|280